Relsys International Launches the Pharmacovigilance Integrated Services Offering and Significantly Expands Project Delivery Capabilities
In 2008, Relsys has delivered numerous Argus Safety(TM) upgrade projects,even as it continues to add new system implementations to its portfolio. ChrisJabbal, Chief Services Officer for Relsys, commented: "This year, our GPSorganization has increased the number of projects delivered by more than 300%over 2007, with several more projects due to be completed before the end ofthe year." New safety database implementations in 2008 have included at leastthree Top 20 pharma companies, as well numerous smaller and mid-sizedcompanies. Jabbal continued: "We have proactively scaled our professionalservices organization to address the growth in our project portfolio. Our teamhas doubled in the past year, as we have hired numerous project managers,analysts and subject matter experts. The Relsys GPS team has the capacity tocontinue to deliver even more new projects in the future."
Relsys has also launched its Integrated Services Offering, focusing ondelivering pharma projects on-time, to-plan and to-budget. Jabbal commented:"We have always been focused on delivering end-to-end drug safety solutions toaddress our clients' pharmacovigilance needs. Our primary vision is toeffectively execute the delivery of the Integrated Services Offering toaddress pharma's pressing safety and risk management needs." To ensuresuccessful execution, Relsys has also implemented a Services QualityManagement System (SQMS) -- a quality assurance system for professionalservices with an explicit goal to increase standards of excellence. "We arevery excited about the new programs -- they are an integral part of our visionto become a world-class services organization," said Jabbal.
Interested parties may learn more about the Integrated Service Offeringsand SQMS by visiting http://www.relsys.net/services or by contacting us email@example.com.
About Relsys International
Relsys International provides the industry-leading Argus suite, a completesystems solution for Drug Safety, Pharmacovigilance and Risk Management thathelps pharmaceutical, biotech and medical device companies improve drug safetyand ensure ongoing compliance with global regulations. The company, founded in1987, works in partnership with its customers to develop and deliverinnovative solutions to long-term business needs, and to provide criticalcomponents to support its clients' corporate risk management strategies. ArgusSafety(TM), the company's flagship product, is the world's widely-used drugsafety and adverse event reporting software. Relsys is a privately heldcompany, headquartered in Irvine, California. For more information, visithttp://www.relsys.net, or call +1 949-453-1715.
SOURCE Relsys International
You May Also Like